| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.025 | 0.8 |